Elsevier regrets faux journals

Elsevier came under fire for a series of deceptive publications published in Australia between 2000 and 2005. The six journals in question, published by Elsevier's Excerpta Medica, resembled legitimate journals, but were in fact sponsored compilations created “on behalf of pharmaceutical clients…and lack[ing] the proper disclosures,” said Michael Hanson, CEO of Elsevier's health sciences division, in a statement. “This was an unacceptable practice, and we regret that it took place.”

One of the journals, Australasian Journal of Bone and Joint Medicine, was allegedly produced entirely by Merck to promote Vioxx, according to a report in The Australian.
You must be a registered member of MMM to post a comment.

Next Article in Features

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters